Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Barrett Esophagus 2Neoplasms, Squamous Cell 1Neoplasms 1Carcinoma in Situ 1

Interventions

Colposcopy 9Imiquimod 7Conization 7Papillomavirus Vaccines 6Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 6Cryotherapy 6human papillomavirus vaccine, L1 type 16, 18 4Blood Specimen Collection 4Vaginal Smears 3Vaccines 3Papanicolaou Test 3VGX-3100 2Topotecan 2Proflavine 2Polymerase Chain Reaction 2Paclitaxel 2Mass Screening 2Human Papillomavirus DNA Tests 2Fluorouracil 2Cisplatin 2Biopsy 2Acetic Acid 24,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2terameprocol 1poly(gamma-glutamic acid) 1methyl 5-aminolevulinate 1lime 1human papillomavirus vaccine, TA 1hecolin 1fludarabine phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Uterine Cervical Dysplasia × Proflavine × Clear all
NCT02206048 2022-07-25

Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix

M.D. Anderson Cancer Center

Phase NA Completed
9 enrolled 5 charts
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT02420665 2021-05-28

Use of High-Resolution Microendoscopy (HRME) in Patients With Cervical Dysplasia

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed
50 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡